Literature DB >> 8434864

Detection of colorectal cancer by faecal alpha 1-antitrypsin.

A Moran1, S Radley, J Neoptolemos, A F Jones, P Asquith.   

Abstract

Alpha 1-antitrypsin was measured in 5-day faecal collections from patients with colorectal cancer or adenomatous polyps and a symptomatic control group. Collections were homogenized and lyophilized prior to measurement of alpha 1-antitrypsin by radial immuno-diffusion. Colorectal cancer dry weight concentrations were significantly higher than the symptomatic control results, with 57% having results greater than 95% normal values of this control group. There was no significant difference between adenomatous polyp dry weight concentrations and symptomatic control results. Wet weight concentrations were calculated from wet/dry ratios. Colorectal cancer wet weight concentrations were significantly higher than symptomatic control results with 48% having results greater than 95% normal values of this control group. Alpha 1-antitrypsin was also measured in non-lyophilized samples from an asymptomatic control group (n = 39). Colorectal cancer wet weight concentrations were significantly higher than asymptomatic control results, with 62% having results greater than 95% normal values of this control group. Faecal alpha 1-antitrypsin measurement deserves further assessment for use in detecting colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434864     DOI: 10.1177/000456329303000105

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  3 in total

Review 1.  Faecal occult blood testing for colorectal cancer screening: the past or the future.

Authors:  Sally C Benton; Helen E Seaman; Stephen P Halloran
Journal:  Curr Gastroenterol Rep       Date:  2015-02

2.  Diagnostic value of a guaiac occult blood test and faecal alpha 1-antitrypsin.

Authors:  A Moran; D Husband; A F Jones; P Asquith
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

3.  Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant.

Authors:  A Moran; M Robinson; N Lawson; J Stanley; A F Jones; J D Hardcastle
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.